PRJNA451379
Whole genome sequencing of Neisseria gonorrhoeae isolates associated with treatment failure from Australia in March 2011; Case 2
Antimicrobial resistant Neisseria gonorrhoeae has become a major global public health issue, with particular concern over isolates exhibiting decreased susceptibility to ceftriaxone becoming widespread. Treatment failures have been previously reported with third-generation cephalosporins, with ceftriaxone considered the last remaining empirical monotherapy for gonorrhoea. Here, we report both the pre- and post-treatment isolates from a treatment failure associated with ceftriaxone monotherapy identified in March 2011. This BioProject includes the complete PacBio genome sequence of TFG-A2.